v3.25.1
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
A and R Plan
Annual Incentive Plan
Common Stock
Common Stock
A and R Plan
Common Stock
Annual Incentive Plan
Additional Paid-In Capital
Additional Paid-In Capital
A and R Plan
Additional Paid-In Capital
Annual Incentive Plan
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance, Shares (in shares) at Mar. 31, 2022 [1]       22,440,616              
Beginning Balance at Mar. 31, 2022 $ 915,656     $ 2     $ 2,110,203     $ 179 $ (1,194,728)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) [1]       137,439              
Issuance of common stock upon exercise of stock options 4,203           4,203        
Issuance of common stock upon release of RSUs (in shares) [1]         353,108            
Issuance of common stock upon release of RSUs   $ 0           $ 0      
Net share settlements for stock-based minimum tax withholdings (in shares) [1]       (3,282)              
Net share settlements for stock-based minimum tax withholdings (197)           (197)        
Issuance of common stock under employee stock purchase plan (in shares) [1]       132,116              
Issuance of common stock under employee stock purchase plan 6,463           6,463        
Stock-based compensation expense 100,269           100,269        
Other comprehensive (loss) income (799)                 (799)  
Net loss (311,656)                   (311,656)
Ending Balance, Shares (in shares) at Mar. 31, 2023 [1]       23,059,997              
Ending Balance at Mar. 31, 2023 713,939     $ 2     2,220,941     (620) (1,506,384)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) [1]       104,136              
Issuance of common stock upon exercise of stock options 909           909        
Issuance of common stock upon release of RSUs (in shares) [1]         634,203 450,953          
Issuance of common stock upon release of RSUs     $ 18,731           $ 18,731    
Net share settlements for stock-based minimum tax withholdings (in shares) [1]       (9,798)              
Net share settlements for stock-based minimum tax withholdings (230)           (230)        
Issuance of common stock under employee stock purchase plan (in shares) [1]       266,479              
Issuance of common stock under employee stock purchase plan 3,262     $ 0     3,262        
Stock-based compensation expense 117,993           117,993        
Other comprehensive (loss) income 620                 620  
Net loss (666,704)                   (666,704)
Ending Balance, Shares (in shares) at Mar. 31, 2024 [1]       24,505,970              
Ending Balance at Mar. 31, 2024 188,520     $ 2     2,361,606     0 (2,173,088)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) [1]       6,889              
Issuance of common stock upon exercise of stock options $ 58           58        
Issuance of common stock upon release of RSUs (in shares) [1]         1,850,573 607,222          
Issuance of common stock upon release of RSUs     $ 6,451           $ 6,451    
Issuance of common stock for rounding in relation to the Reverse Stock Split (in shares) [1] 281,210                    
Issuance of common stock for rounding in relation to the Reverse Stock Split $ 0     $ 1     (1)        
Net share settlements for stock-based minimum tax withholdings (in shares) [1]       (25,346)              
Net share settlements for stock-based minimum tax withholdings (150)           (150)        
Issuance of common stock under employee stock purchase plan (in shares) [1]       212,862              
Issuance of common stock under employee stock purchase plan 613           613        
Stock-based compensation expense 58,651           58,651        
Other comprehensive (loss) income 0                    
Net loss (280,885)                   (280,885)
Ending Balance, Shares (in shares) at Mar. 31, 2025 [1]       27,439,380              
Ending Balance at Mar. 31, 2025 $ (26,742)     $ 3     $ 2,427,228     $ 0 $ (2,453,973)
[1] Amounts have been adjusted to reflect the reverse stock split that became effective on October 16, 2024. Refer to Note 14, “Stockholders' Equity,” for further information about the reverse stock split.